EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis
Europe - FRA:EWL - US28176E1082 - Common Stock
63.09 EUR
+0.56 (+0.9%)
EWL gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 59 industry peers in the Health Care Equipment & Supplies industry. EWL gets an excellent profitability rating and is at the same time showing great financial health properties. EWL is quite expensive at the moment. It does show a decent growth rate. These ratings would make EWL suitable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year EWL was profitable.
In the past year EWL had a positive cash flow from operations.
Each year in the past 5 years EWL has been profitable.
Each year in the past 5 years EWL had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 30.75%, EWL belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
EWL has a better Return On Equity (39.33%) than 98.31% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.25%, EWL is in the better half of the industry, outperforming 74.58% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for EWL is above the industry average of 9.04%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.75% | ||
| ROE | 39.33% | ||
| ROIC | 9.25% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
1.3 Margins
EWL has a better Profit Margin (72.96%) than 100.00% of its industry peers.
EWL's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 27.94%, EWL belongs to the top of the industry, outperforming 94.92% of the companies in the same industry.
In the last couple of years the Operating Margin of EWL has remained more or less at the same level.
EWL has a Gross Margin of 78.87%. This is amongst the best in the industry. EWL outperforms 93.22% of its industry peers.
EWL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.94% | ||
| PM (TTM) | 72.96% | ||
| GM | 78.87% |
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
2. Health
2.1 Basic Checks
EWL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for EWL has been reduced compared to 1 year ago.
EWL has less shares outstanding than it did 5 years ago.
EWL has a better debt/assets ratio than last year.
2.2 Solvency
EWL has an Altman-Z score of 11.53. This indicates that EWL is financially healthy and has little risk of bankruptcy at the moment.
EWL has a Altman-Z score of 11.53. This is amongst the best in the industry. EWL outperforms 94.92% of its industry peers.
EWL has a debt to FCF ratio of 1.03. This is a very positive value and a sign of high solvency as it would only need 1.03 years to pay back of all of its debts.
The Debt to FCF ratio of EWL (1.03) is better than 84.75% of its industry peers.
EWL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
EWL's Debt to Equity ratio of 0.06 is amongst the best of the industry. EWL outperforms 84.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 1.03 | ||
| Altman-Z | 11.53 |
ROIC/WACC1.08
WACC8.56%
2.3 Liquidity
A Current Ratio of 4.68 indicates that EWL has no problem at all paying its short term obligations.
EWL's Current ratio of 4.68 is amongst the best of the industry. EWL outperforms 94.92% of its industry peers.
A Quick Ratio of 3.87 indicates that EWL has no problem at all paying its short term obligations.
EWL has a Quick ratio of 3.87. This is amongst the best in the industry. EWL outperforms 94.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.68 | ||
| Quick Ratio | 3.87 |
3. Growth
3.1 Past
The earnings per share for EWL have decreased by -0.77% in the last year.
EWL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.13% yearly.
EWL shows a decrease in Revenue. In the last year, the revenue decreased by -1.09%.
Measured over the past years, EWL shows a small growth in Revenue. The Revenue has been growing by 4.58% on average per year.
EPS 1Y (TTM)-0.77%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%-4.29%
Revenue 1Y (TTM)-1.09%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%-6.13%
3.2 Future
The Earnings Per Share is expected to grow by 9.38% on average over the next years. This is quite good.
Based on estimates for the next years, EWL will show a quite strong growth in Revenue. The Revenue will grow by 8.39% on average per year.
EPS Next Y-1.75%
EPS Next 2Y4.72%
EPS Next 3Y7.26%
EPS Next 5Y9.38%
Revenue Next Year3.65%
Revenue Next 2Y6.66%
Revenue Next 3Y7.84%
Revenue Next 5Y8.39%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
EWL is valuated quite expensively with a Price/Earnings ratio of 28.68.
The rest of the industry has a similar Price/Earnings ratio as EWL.
When comparing the Price/Earnings ratio of EWL to the average of the S&P500 Index (27.69), we can say EWL is valued inline with the index average.
A Price/Forward Earnings ratio of 25.65 indicates a quite expensive valuation of EWL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EWL is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.18, EWL is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.68 | ||
| Fwd PE | 25.65 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as EWL.
The rest of the industry has a similar Price/Free Cash Flow ratio as EWL.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 74.87 | ||
| EV/EBITDA | 22.42 |
4.3 Compensation for Growth
The excellent profitability rating of EWL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.02
EPS Next 2Y4.72%
EPS Next 3Y7.26%
5. Dividend
5.1 Amount
No dividends for EWL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:EWL (10/17/2025, 7:00:00 PM)
63.09
+0.56 (+0.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.08%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap37.04B
Analysts76.28
Price Target76.64 (21.48%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.25%
Min EPS beat(2)4.11%
Max EPS beat(2)4.4%
EPS beat(4)4
Avg EPS beat(4)3.37%
Min EPS beat(4)1.57%
Max EPS beat(4)4.4%
EPS beat(8)4
Avg EPS beat(8)0.66%
EPS beat(12)5
Avg EPS beat(12)0.01%
EPS beat(16)6
Avg EPS beat(16)-0.9%
Revenue beat(2)0
Avg Revenue beat(2)-1.11%
Min Revenue beat(2)-2.1%
Max Revenue beat(2)-0.12%
Revenue beat(4)0
Avg Revenue beat(4)-4.22%
Min Revenue beat(4)-13.79%
Max Revenue beat(4)-0.12%
Revenue beat(8)0
Avg Revenue beat(8)-3.15%
Revenue beat(12)1
Avg Revenue beat(12)-2.51%
Revenue beat(16)1
Avg Revenue beat(16)-2.76%
PT rev (1m)1.3%
PT rev (3m)5.52%
EPS NQ rev (1m)0.67%
EPS NQ rev (3m)-0.98%
EPS NY rev (1m)0.14%
EPS NY rev (3m)0.7%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)0.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.68 | ||
| Fwd PE | 25.65 | ||
| P/S | 7.61 | ||
| P/FCF | 74.87 | ||
| P/OCF | 54.43 | ||
| P/B | 4.1 | ||
| P/tB | 5.7 | ||
| EV/EBITDA | 22.42 |
EPS(TTM)2.2
EY3.49%
EPS(NY)2.46
Fwd EY3.9%
FCF(TTM)0.84
FCFY1.34%
OCF(TTM)1.16
OCFY1.84%
SpS8.29
BVpS15.38
TBVpS11.08
PEG (NY)N/A
PEG (5Y)4.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.75% | ||
| ROE | 39.33% | ||
| ROCE | 13.14% | ||
| ROIC | 9.25% | ||
| ROICexc | 13.94% | ||
| ROICexgc | 22.05% | ||
| OM | 27.94% | ||
| PM (TTM) | 72.96% | ||
| GM | 78.87% | ||
| FCFM | 10.17% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
ROICexc(3y)16.13%
ROICexc(5y)17.4%
ROICexgc(3y)22.87%
ROICexgc(5y)24.4%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexcg growth 3Y-5.47%
ROICexcg growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score7
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 1.03 | ||
| Debt/EBITDA | 0.34 | ||
| Cap/Depr | 142.95% | ||
| Cap/Sales | 3.82% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 45.68% | ||
| Profit Quality | 13.93% | ||
| Current Ratio | 4.68 | ||
| Quick Ratio | 3.87 | ||
| Altman-Z | 11.53 |
F-Score7
WACC8.56%
ROIC/WACC1.08
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.77%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%-4.29%
EPS Next Y-1.75%
EPS Next 2Y4.72%
EPS Next 3Y7.26%
EPS Next 5Y9.38%
Revenue 1Y (TTM)-1.09%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%-6.13%
Revenue Next Year3.65%
Revenue Next 2Y6.66%
Revenue Next 3Y7.84%
Revenue Next 5Y8.39%
EBIT growth 1Y0.21%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year10.47%
EBIT Next 3Y11.73%
EBIT Next 5Y12.05%
FCF growth 1Y-15.26%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-15.47%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%